110 related articles for article (PubMed ID: 16623271)
1. [The complications during the therapy for multiple myeloma].
Spicka I
Vnitr Lek; 2006 Feb; 52(2):115. PubMed ID: 16623271
[No Abstract] [Full Text] [Related]
2. Reduced serum levels of Interleukin 17 in patients with osteonecrosis of the jaw and in multiple myeloma subjects after bisphosphonates administration.
Oteri G; Allegra A; Bellomo G; Alonci A; Nastro E; Penna G; Catalfamo L; Cicciù D; De Ponte FS; Musolino C
Cytokine; 2008 Aug; 43(2):103-4. PubMed ID: 18585926
[No Abstract] [Full Text] [Related]
3. Multiple myeloma.
Altundag K; Altundag O; Gundeslioglu O
N Engl J Med; 2005 Feb; 352(8):840-1; author reply 840-1. PubMed ID: 15728824
[No Abstract] [Full Text] [Related]
4. The incidence of jaw osteonecrosis in multiple myeloma patients treated with bisphosphonates.
Kraj M; Pogłód R; Maj S; Owczarska K
Acta Pol Pharm; 2006; 63(5):450-2. PubMed ID: 17357613
[No Abstract] [Full Text] [Related]
5. [Osteonecrosis of the jaw in the course of multiple myeloma treatment and bisphosphonate administration].
Adam Z; Kozumpliková M; Pour L; Machálka M
Vnitr Lek; 2006 Feb; 52(2):176-80. PubMed ID: 16623282
[TBL] [Abstract][Full Text] [Related]
6. Osteonecrosis of the jaw and bisphosphonates.
Durie BG; Katz M; Crowley J
N Engl J Med; 2005 Jul; 353(1):99-102; discussion 99-102. PubMed ID: 16000365
[No Abstract] [Full Text] [Related]
7. Survey of members of myeloma UK on biphosphonates-associated jaw osteonecrosis.
Barker K; Lowe D; Olujohungbe A; Low E; Rogers SN
Br J Haematol; 2007 Nov; 139(4):626-8. PubMed ID: 17922879
[No Abstract] [Full Text] [Related]
8. [Osteonecrosis of the jaw associated with the use of bisphosphonates in multiple myeloma: report of four cases and literature review].
Li LH; Wu XB; Chen WM; Chen JX; Wu Y; Chen SL
Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(42):2986-7. PubMed ID: 19080077
[TBL] [Abstract][Full Text] [Related]
9. Why osteonecrosis of the jaw after bisphosphonates treatment is more frequent in multiple myeloma than in solid tumors.
Delibasi T; Altundag K; Kanlioglu Y
J Oral Maxillofac Surg; 2006 Jun; 64(6):995-6. PubMed ID: 16713825
[No Abstract] [Full Text] [Related]
10. Bisphosphonate-induced osteonecrosis of the jaw: long-term outcomes.
Katz J; George T; Sandow P; Machado M; Dickerson L; Moreb JS
J Support Oncol; 2009; 7(1):9-10. PubMed ID: 19278171
[No Abstract] [Full Text] [Related]
11. [Avascular jaw osteonecrosis associated with bisphophonate therapy].
Broglia C; Merlati G; Valentino F; Benatti C; Gobbi P; Ascari E
Recenti Prog Med; 2006 Mar; 97(3):140-4. PubMed ID: 16700419
[TBL] [Abstract][Full Text] [Related]
12. A time for perspective on bisphosphonates.
Assael LA
J Oral Maxillofac Surg; 2006 Jun; 64(6):877-9. PubMed ID: 16713799
[No Abstract] [Full Text] [Related]
13. The dilemma of jaw osteonecrosis in patients with multiple myeloma.
Gertz MA; Koka S
Leuk Lymphoma; 2008 Nov; 49(11):2037-9. PubMed ID: 19021045
[No Abstract] [Full Text] [Related]
14. Use of bisphosphonates in multiple myeloma: IMWG response to Mayo Clinic consensus statement.
Durie BG
Mayo Clin Proc; 2007 Apr; 82(4):516-7; author reply 517-8. PubMed ID: 17418085
[No Abstract] [Full Text] [Related]
15. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.
Ruggiero SL; Fantasia J; Carlson E
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):433-41. PubMed ID: 16997108
[No Abstract] [Full Text] [Related]
16. Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid.
Dimopoulos MA; Kastritis E; Anagnostopoulos A; Melakopoulos I; Gika D; Moulopoulos LA; Bamia C; Terpos E; Tsionos K; Bamias A
Haematologica; 2006 Jul; 91(7):968-71. PubMed ID: 16757414
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonates--role in cancer therapies.
Mehrotra B
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):19-26. PubMed ID: 19371811
[No Abstract] [Full Text] [Related]
18. Osteonecrosis of the jaw associated with zoledronate therapy in a patient with multiple myeloma.
Vannucchi AM; Ficarra G; Antonioli E; Bosi A
Br J Haematol; 2005 Mar; 128(6):738. PubMed ID: 15755276
[No Abstract] [Full Text] [Related]
19. [Rapid drug information].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr; 48(4):506-7. PubMed ID: 15830265
[No Abstract] [Full Text] [Related]
20. Bisphosphonate-associated osteonecrosis of the jaw: conclusions based on an analysis of case series.
Landesberg R; Wilson T; Grbic JT
Dent Today; 2006 Aug; 25(8):52, 54-7. PubMed ID: 16925161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
